🎙️ ASCO-GU Interview | Dr. Neal D. Shore: Examining Outcomes of Men with High-Risk Biochemically Recurrent Prostate Cancer Who Suspended Enzalutamide Monotherapy Treatment in the Phase 3 EMBARK Study. 🔍
Home » 🎙️ ASCO-GU Interview | Dr. Neal D. Shore: Examining Outcomes of Men with High-Risk Biochemically Recurrent Prostate Cancer Who Suspended Enzalutamide Monotherapy Treatment in the Phase 3 EMBARK Study. 🔍
